Fig. 6From: A 13-gene expression-based radioresistance score highlights the heterogeneity in the response to radiation therapy across HPV-negative HNSCC molecular subtypesFibronectin and cyclin D1 expression in radiosensitive and radioresistant cancer cell lines and in molecular subtypes of human papillomavirus (HPV)-negative head and neck squamous cell carcinoma (HNSCC). Protein expression levels of fibronectin and cyclin D1 were (a) compared between groups of NCI60 cancer cell lines defined by different ranges of survival fraction at 2Ā Gy (SF2) (KruskalāWallis test) and (b) compared between molecular subtypes of HNSCC in HPV-negative HNSCC from The Cancer Genome AtlasBack to article page